393 related articles for article (PubMed ID: 29181692)
1. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
[TBL] [Abstract][Full Text] [Related]
2. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
[TBL] [Abstract][Full Text] [Related]
3. Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
Dietrich S; Floegel A; Weikert C; Prehn C; Adamski J; Pischon T; Boeing H; Drogan D
Hypertension; 2016 Aug; 68(2):471-7. PubMed ID: 27245178
[TBL] [Abstract][Full Text] [Related]
4. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam.
Floegel A; von Ruesten A; Drogan D; Schulze MB; Prehn C; Adamski J; Pischon T; Boeing H
Eur J Clin Nutr; 2013 Oct; 67(10):1100-8. PubMed ID: 23942179
[TBL] [Abstract][Full Text] [Related]
5. Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam study.
Bachlechner U; Floegel A; Steffen A; Prehn C; Adamski J; Pischon T; Boeing H
Nutr Diabetes; 2016 Jun; 6(6):e215. PubMed ID: 27348203
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
[TBL] [Abstract][Full Text] [Related]
8. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
[TBL] [Abstract][Full Text] [Related]
9. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
10. A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke.
Lind L; Salihovic S; Ganna A; Sundström J; Broeckling CD; Magnusson PK; Pedersen NL; Siegbahn A; Prenni J; Fall T; Ingelsson E; Ärnlöv J
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104476. PubMed ID: 31806450
[TBL] [Abstract][Full Text] [Related]
11. Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
Menzel J; di Giuseppe R; Biemann R; Wittenbecher C; Aleksandrova K; Pischon T; Fritsche A; Schulze MB; Boeing H; Isermann B; Weikert C
Atherosclerosis; 2016 Aug; 251():415-421. PubMed ID: 27298015
[TBL] [Abstract][Full Text] [Related]
12. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
Carayol M; Leitzmann MF; Ferrari P; Zamora-Ros R; Achaintre D; Stepien M; Schmidt JA; Travis RC; Overvad K; Tjønneland A; Hansen L; Kaaks R; Kühn T; Boeing H; Bachlechner U; Trichopoulou A; Bamia C; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Quirós JR; Sánchez-Cantalejo E; Huerta JM; Ardanaz E; Arriola L; Agudo A; Nilsson J; Melander O; Bueno-de-Mesquita B; Peeters PH; Wareham N; Khaw KT; Jenab M; Key TJ; Scalbert A; Rinaldi S
J Proteome Res; 2017 Sep; 16(9):3137-3146. PubMed ID: 28758405
[TBL] [Abstract][Full Text] [Related]
13. Circulating metabolites associated with incident myocardial infarction and stroke: A prospective cohort study of 90 438 participants.
Guo Y; Chen SF; Zhang YR; Wang HF; Huang SY; Chen SD; Deng YT; Wu BS; Kuo K; Wang RZ; Dong Q; Feng JF; Cheng W; Yu JT
J Neurochem; 2022 Aug; 162(4):371-384. PubMed ID: 35762284
[TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolite networks from four German population-based studies.
Iqbal K; Dietrich S; Wittenbecher C; Krumsiek J; Kühn T; Lacruz ME; Kluttig A; Prehn C; Adamski J; von Bergen M; Kaaks R; Schulze MB; Boeing H; Floegel A
Int J Epidemiol; 2018 Dec; 47(6):2070-2081. PubMed ID: 29982629
[TBL] [Abstract][Full Text] [Related]
15. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg).
Li K; Kaaks R; Linseisen J; Rohrmann S
Heart; 2012 Jun; 98(12):920-5. PubMed ID: 22626900
[TBL] [Abstract][Full Text] [Related]
16. Microsomal triglyceride transfer protein -164 T > C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study.
di Giuseppe R; Pechlivanis S; Fisher E; Arregui M; Weikert B; Knüppel S; Buijsse B; Fritsche A; Willich SN; Joost HG; Boeing H; Moebus S; Weikert C
BMC Med Genet; 2013 Jan; 14():19. PubMed ID: 23356586
[TBL] [Abstract][Full Text] [Related]
17. Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels.
Pischon T; Möhlig M; Hoffmann K; Spranger J; Weikert C; Willich SN; Pfeiffer AF; Boeing H
Eur J Epidemiol; 2007; 22(7):429-38. PubMed ID: 17557140
[TBL] [Abstract][Full Text] [Related]
18. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.
di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
Eur J Epidemiol; 2015 Feb; 30(2):131-41. PubMed ID: 25527370
[TBL] [Abstract][Full Text] [Related]
19. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.
Holmes MV; Millwood IY; Kartsonaki C; Hill MR; Bennett DA; Boxall R; Guo Y; Xu X; Bian Z; Hu R; Walters RG; Chen J; Ala-Korpela M; Parish S; Clarke RJ; Peto R; Collins R; Li L; Chen Z;
J Am Coll Cardiol; 2018 Feb; 71(6):620-632. PubMed ID: 29420958
[TBL] [Abstract][Full Text] [Related]
20. Plasma
Wittenbecher C; Štambuk T; Kuxhaus O; Rudman N; Vučković F; Štambuk J; Schiborn C; Rahelić D; Dietrich S; Gornik O; Perola M; Boeing H; Schulze MB; Lauc G
Diabetes Care; 2020 Mar; 43(3):661-668. PubMed ID: 31915204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
